By Abigail Townsend
Date: Tuesday 23 Sep 2025
(Sharecast News) - Oxford Biomedica reiterated full-year guidance on Tuesday, after the biopharma saw strong demand throughout the first half and trimmed losses.
Total Voting Rights | 01-Oct-2025 | 07:00 | RNS |
Interim Results for 6 months ended 30 June 2025 | 23-Sep-2025 | 07:00 | RNS |
Total Voting Rights | 01-Sep-2025 | 07:00 | RNS |
PDMR Dealings | 22-Aug-2025 | 15:36 | RNS |
Holding(s) in Company | 21-Aug-2025 | 10:24 | RNS |
Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
Need to know | 10-May-2008 | Times |
DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
Oxford BioMedica clinches $690m licensing deal f... | 29-Mar-2007 | The Independent |
Oxford Biomedica seals €518m deal with Sanofi ov... | 29-Mar-2007 | Times |
No recent information was found.
Currency | UK Pounds |
Share Price | 615.00p |
Change Today | 19.00p |
% Change | 3.19 % |
52 Week High | 630.00 |
52 Week Low | 232.50 |
Volume | 225,031 |
Shares Issued | 120.21m |
Market Cap | £739.27m |
Beta | 0.00 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
16:47 | 3,678 @ 613.10p |
16:35 | 4 @ 615.00p |
16:35 | 1,026 @ 615.00p |
16:35 | 55,961 @ 615.00p |
16:35 | 276 @ 615.00p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research